BioLife Solutions Stock Forecast for 2023 - 2025 - 2030

Updated on 04/18/2024

Stock Rating
9
Price Target
$21.50
Consensus
Outperform
Upside
42.01%
Analysts
1
Stock Rating
9
Upside
42.01%
Analysts
1
Price Target
$21.50

BioLife Solutions Stock Forecast and Price Target

If the average price target of $21.50 set by distinguished experts for BioLife Solutions over the past few weeks is reached this year, there would be a potential upside of approximately 42.01% from the last closing price in April, 2024. This potential increase is based on a high estimate of $30.00 and a low estimate of $20.00. If you are interested in BLFS stock, you should also look at its competitors.

$21.50

42.01% Upside

Buy
Buy

BioLife Solutions Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, BioLife Solutions's Price has decreased from $0.58 to $0.00 – a 100.00% drop. Next year, analysts are expecting Fair Value to reach $16.33 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$16.33
2025 Fair Value Forecast
$18.16
2026 Fair Value Forecast
$20.19
2027 Fair Value Forecast
$22.45
2028 Fair Value Forecast
$24.96
2029 Fair Value Forecast
$27.75
2030 Fair Value Forecast
$30.86

BioLife Solutions Revenue Forecast for 2023 - 2025 - 2030

In the last two years, BioLife Solutions's Revenue has grown from $48.09M to $161.76M – a 236.37% increase. For the following year, the 7 analysts predict that BioLife Solutions's Revenue will drop by 4.57%, reaching $154.37M. Over the next seven years, the forecast is for Revenue to grow by 344.88%.

2024 Rev Forecast
$0.15B
2025 Rev Forecast
$0.20B
2026 Rev Forecast
$0.28B
2027 Rev Forecast
$0.37B
2028 Rev Forecast
$0.46B
2029 Rev Forecast
$0.58B
2030 Rev Forecast
$0.72B

BioLife Solutions Dividend per Share Forecast for 2023 - 2025 - 2030

BioLife Solutions Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.00B
2025 FCF Forecast
$0.02B
2026 FCF Forecast
$0.02B
2027 FCF Forecast
$0.04B
2028 FCF Forecast
$0.06B
2029 FCF Forecast
$0.09B
2030 FCF Forecast
$0.13B

BioLife Solutions EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, BioLife Solutions has seen a decline in its EBITDA, from $2.15M to $-23.19M – a 1178.60% decrease. According to the 3 analysts polled, in the next year, BioLife Solutions's EBITDA will fall by 42.82%, reaching $-13.26M. By 2030, professionals believe that BioLife Solutions's EBITDA will have decreased by 238.07%, falling to $32.02M.

2024 EBITDA Forecast
$-13260000.00
2025 EBITDA Forecast
$0.02B
2026 EBITDA Forecast
$0.05B
2027 EBITDA Forecast
$0.03B
2028 EBITDA Forecast
$0.02B
2029 EBITDA Forecast
$0.02B
2030 EBITDA Forecast
$0.03B

BioLife Solutions EBIT Forecast for 2023 - 2025 - 2030

BioLife Solutions's EBIT has grown In the last two years, rising from $-2.92M to $-39.66M – a growth of 1258.22%. In the next year, analysts believe that EBIT will reach $-53.41M – an increase of 34.67%. By 2030, professionals believe that BioLife Solutions's EBIT will decrease by 437.67%, reaching $133.92M – a concerning trend for the company.

2024 EBIT Forecast
$-53410000.00
2025 EBIT Forecast
$-8030000.00
2026 EBIT Forecast
$0.01B
2027 EBIT Forecast
$0.03B
2028 EBIT Forecast
$0.05B
2029 EBIT Forecast
$0.09B
2030 EBIT Forecast
$0.13B

BioLife Solutions EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, BioLife Solutions's EPS has decreased from $0.01 to $0.00 – a 100.00% drop. Next year, analysts are expecting EPS to reach $-0.41 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$-0.41
2025 EPS Forecast
$0.69
2026 EPS Forecast
$1.43
2027 EPS Forecast
$2.41
2028 EPS Forecast
$3.30
2029 EPS Forecast
$4.36
2030 EPS Forecast
$5.10